Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

C9 Antikörper (AA 136-512)

C9 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN5013382
  • Target Alle C9 Antikörper anzeigen
    C9 (Complement Component C9 (C9))
    Bindungsspezifität
    • 16
    • 9
    • 6
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 136-512
    Reaktivität
    • 58
    • 3
    • 2
    • 2
    • 2
    • 2
    Maus
    Wirt
    • 49
    • 11
    • 1
    • 1
    Kaninchen
    Klonalität
    • 50
    • 11
    Polyklonal
    Konjugat
    • 29
    • 8
    • 4
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser C9 Antikörper ist unkonjugiert
    Applikation
    • 47
    • 24
    • 23
    • 21
    • 12
    • 10
    • 10
    • 7
    • 7
    • 6
    • 6
    • 2
    • 2
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
    Verwendungszweck
    Polyclonal Antibody to Complement Component 9 (C9)
    Spezifität
    The antibody is a rabbit polyclonal antibody raised against C9. It has been selected for its ability to recognize C9 in immunohistochemical staining and western blotting.
    Aufreinigung
    Antigen-specific affinity chromatography followed by Protein A affinity chromatography
    Immunogen
    Recombinant Complement Component 9 (C9) corresdonding to Pro136~Arg512 with N-terminal His Tag
    Isotyp
    IgG
    Top Product
    Discover our top product C9 Primärantikörper
  • Applikationshinweise

    Western blotting: 0.5-2 μg/mL

    Immunohistochemistry: 5-20 μg/mL

    Immunocytochemistry: 5-20 μg/mL

    Optimal working dilutions must be determined by end user.

    Kommentare

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    Lot specific
    Buffer
    0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.
    Konservierungsmittel
    ProClin
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
    Haltbarkeit
    24 months
  • Sones, Merriam, Seffens, Brown-Grant, Butler, Zhao, Xu, Shawber, Grenier, Douglas: "Angiogenic factor imbalance precedes complement deposition in placentae of the BPH/5 model of preeclampsia." in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 32, Issue 5, pp. 2574-2586, (2018) (PubMed).

    Fu, Ju, Lin, Xiao, Li, Zhuang, Zhang, Ma, Li, Ma, Su, Wang, Qin, Liang: "Target deletion of complement component 9 attenuates antibody-mediated hemolysis and lipopolysaccharide (LPS)-induced acute shock in mice." in: Scientific reports, Vol. 6, pp. 30239, (2016) (PubMed).

  • Target
    C9 (Complement Component C9 (C9))
    Andere Bezeichnung
    Complement Component 9 (C9 Produkte)
    Synonyme
    LOC100037951 antikoerper, LOC100136130 antikoerper, c9 antikoerper, wu:fb60b05 antikoerper, wu:fd50e04 antikoerper, zgc:112272 antikoerper, complement C9 antikoerper, complement component 9 antikoerper, complement component 9 L homeolog antikoerper, C9 antikoerper, c9 antikoerper, c9.L antikoerper
    Pathways
    Komplementsystem
Sie sind hier:
Kundenservice